Details for 2019817846

Up to date per 02.04.2026

Actions

Title / Product Name

INTRALÄSIONALE VERABREICHUNG VON PD-1 INHIBITOREN ZUR KREBSBEHANDLUNG

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2019817846

EP Publication Number

3880186

E-Number

1671478

Language

PCT Number

US19061212

Publication Date

22.09.2021 A

03.04.2024 B1

Registration Date

03.04.2024

AT Publication Date

15.04.2024

Application Date

13.11.2019

Registration Number

Priorities

14.11.2018

201862767218 P

IPC

A61K 31/00 20060101AFI20200522BHEP

Maximum Duration of Protection

13.11.2039

Owner

Regeneron Pharmaceuticals, Inc.777 Old Saw Mill River Road Tarrytown, NY 10591-6706US

Representative

Patentanwaltskanzlei Matschnig & Forsthuber OGBiberstraße 221010 WienAT

Inventor

FURY, Matthew G.c/o Regeneron Pharmaceuticals, Inc. 777 Old Saw Mill River Road Tarrytown, NY 10591US

LOWY, Israelc/o Regeneron Pharmaceuticals, Inc. 777 Old Saw Mill River Road Tarrytown, NY 10591US

Information about Fees